News
-
-
-
-
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces a major new scientific publication on TOTUM-448, an active substance designed to treat metabolic liver disease (MASLD)
Valbiotis announces publication in Scientific Reports on TOTUM-448, active substance for metabolic liver disease, presenting results from human study -
-
-
-
PRESS RELEASE
EXAIL TECHNOLOGIES S.A. LAUNCHES A TAP OFFERING OF UNDATED BONDS CONVERTIBLE INTO NEW SHARES AND/OR EXCHANGEABLE FOR EXISTING SHARES (ODIRNANE) FOR A NOMINAL AMOUNT OF EUR 150 MILLION - WITH AN UPSIZE OPTION OF EUR 25 MILLION
Exail Technologies S.A. launches a tap offering of undated bonds convertible into new shares and/or exchangeable for existing shares worth €150 million, assimilated to previous issuance